Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | XENE |
---|---|---|
09:32 ET | 1184 | 43.58 |
09:41 ET | 100 | 43.59 |
09:43 ET | 661 | 43.68 |
09:45 ET | 200 | 43.45 |
09:50 ET | 650 | 43.5628 |
09:56 ET | 188 | 43.41 |
09:59 ET | 100 | 43.5 |
10:01 ET | 100 | 43.36 |
10:10 ET | 200 | 43.36 |
10:12 ET | 100 | 43.24 |
10:14 ET | 200 | 43.14 |
10:15 ET | 500 | 43.255 |
10:17 ET | 500 | 43.3 |
10:21 ET | 300 | 43.195 |
10:28 ET | 1400 | 42.87 |
10:30 ET | 100 | 42.98 |
10:32 ET | 817 | 42.915 |
10:33 ET | 1025 | 42.91 |
10:35 ET | 100 | 42.97 |
10:39 ET | 250 | 43.0571 |
10:44 ET | 200 | 43.07 |
10:46 ET | 1002 | 43.17 |
10:50 ET | 100 | 43.15 |
10:51 ET | 500 | 43.16 |
10:57 ET | 200 | 43.165 |
11:00 ET | 400 | 43.09 |
11:02 ET | 500 | 43.12 |
11:04 ET | 101 | 43.165 |
11:06 ET | 657 | 43.25 |
11:08 ET | 1400 | 43.4 |
11:09 ET | 200 | 43.335 |
11:13 ET | 200 | 43.33 |
11:22 ET | 300 | 43.29 |
11:26 ET | 5232 | 43.56 |
11:27 ET | 100 | 43.56 |
11:31 ET | 100 | 43.45 |
11:33 ET | 400 | 43.535 |
11:36 ET | 220 | 43.6 |
11:40 ET | 400 | 43.55 |
11:42 ET | 100 | 43.545 |
11:45 ET | 200 | 43.47 |
11:49 ET | 120 | 43.42 |
11:54 ET | 2100 | 43.445 |
11:58 ET | 1272 | 43.49 |
12:00 ET | 2300 | 43.49 |
12:02 ET | 100 | 43.5 |
12:07 ET | 200 | 43.53 |
12:09 ET | 296 | 43.5 |
12:12 ET | 200 | 43.5 |
12:14 ET | 100 | 43.54 |
12:16 ET | 400 | 43.51 |
12:18 ET | 100 | 43.52 |
12:21 ET | 533 | 43.52 |
12:25 ET | 100 | 43.555 |
12:34 ET | 200 | 43.5 |
12:38 ET | 470 | 43.5 |
12:39 ET | 100 | 43.52 |
12:41 ET | 2700 | 43.49 |
12:43 ET | 100 | 43.55 |
12:50 ET | 200 | 43.52 |
12:52 ET | 300 | 43.49 |
12:54 ET | 1200 | 43.485 |
12:56 ET | 2839 | 43.485 |
12:57 ET | 400 | 43.5 |
12:59 ET | 600 | 43.505 |
01:01 ET | 3482 | 43.51 |
01:03 ET | 2862 | 43.36 |
01:08 ET | 100 | 43.375 |
01:10 ET | 128 | 43.36 |
01:12 ET | 300 | 43.37 |
01:14 ET | 100 | 43.37 |
01:15 ET | 700 | 43.37 |
01:19 ET | 200 | 43.31 |
01:24 ET | 100 | 43.3 |
01:28 ET | 200 | 43.29 |
01:33 ET | 400 | 43.225 |
01:35 ET | 400 | 43.25 |
01:37 ET | 100 | 43.235 |
01:42 ET | 4736 | 43.46 |
01:44 ET | 100 | 43.4 |
01:46 ET | 200 | 43.37 |
01:48 ET | 2600 | 43.53 |
01:50 ET | 300 | 43.48 |
01:53 ET | 400 | 43.44 |
01:55 ET | 200 | 43.475 |
01:57 ET | 100 | 43.51 |
02:04 ET | 1078 | 43.59 |
02:08 ET | 1918 | 43.57 |
02:11 ET | 500 | 43.55 |
02:15 ET | 819 | 43.5 |
02:18 ET | 200 | 43.49 |
02:20 ET | 300 | 43.47 |
02:22 ET | 423 | 43.495 |
02:26 ET | 1200 | 43.43 |
02:27 ET | 400 | 43.4 |
02:29 ET | 3700 | 43.4 |
02:31 ET | 100 | 43.4 |
02:33 ET | 100 | 43.43 |
02:36 ET | 100 | 43.445 |
02:38 ET | 1900 | 43.43 |
02:40 ET | 600 | 43.42 |
02:42 ET | 1400 | 43.4 |
02:44 ET | 700 | 43.38 |
02:45 ET | 200 | 43.4 |
02:47 ET | 200 | 43.41 |
02:51 ET | 500 | 43.4 |
02:54 ET | 1200 | 43.4 |
02:56 ET | 400 | 43.47 |
02:58 ET | 100 | 43.465 |
03:00 ET | 4634 | 43.455 |
03:02 ET | 9613 | 43.46 |
03:03 ET | 2000 | 43.5 |
03:05 ET | 820 | 43.42 |
03:07 ET | 1500 | 43.49 |
03:09 ET | 200 | 43.51 |
03:12 ET | 1300 | 43.455 |
03:14 ET | 636 | 43.51 |
03:16 ET | 648 | 43.53 |
03:18 ET | 400 | 43.46 |
03:21 ET | 1206 | 43.52 |
03:23 ET | 500 | 43.535 |
03:25 ET | 100 | 43.525 |
03:27 ET | 2026 | 43.54 |
03:30 ET | 100 | 43.5 |
03:32 ET | 1010 | 43.525 |
03:36 ET | 1139 | 43.56 |
03:38 ET | 700 | 43.51 |
03:39 ET | 200 | 43.55 |
03:41 ET | 332 | 43.481 |
03:43 ET | 2900 | 43.53 |
03:45 ET | 200 | 43.55 |
03:48 ET | 2720 | 43.6 |
03:50 ET | 800 | 43.62 |
03:52 ET | 2998 | 43.61 |
03:54 ET | 700 | 43.615 |
03:56 ET | 14283 | 43.67 |
03:57 ET | 3095 | 43.64 |
03:59 ET | 11266 | 43.75 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Xenon Pharmaceuticals Inc | 3.3B | -16.0x | --- |
SpringWorks Therapeutics Inc | 3.3B | -8.8x | --- |
Janux Therapeutics Inc | 3.3B | -48.3x | --- |
Summit Therapeutics Inc | 3.1B | -2.9x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Apogee Therapeutics Inc | 3.1B | -31.2x | --- |
Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the treatment of epilepsy, MDD and potentially other neurological disorders. Its XEN1101 Phase III epilepsy program includes two identical Phase III clinical trials, called X-TOLE2 and X-TOLE3, that are designed closely after the Phase IIb X-TOLE clinical trial. Its Phase III X-ACKT clinical trial is intended to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic-clonic seizures (PGTCS).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.3B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 75.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.26 |
EPS | $-2.73 |
Book Value | $12.31 |
P/E Ratio | -16.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.